Bicara Therapeutics Inc. (BCAX) — 10-Q Filings

10-Q Filings (4)

• Bicara's Losses Double Amid Soaring R&D Costs — Nov 10, 2025 Risk: high
  Bicara Therapeutics Inc. reported a significant increase in net loss for the three and nine months ended September 30, 2025, primarily driven by escalating rese
• Bicara's Q2 Loss Widens Amid Soaring R&D Costs — Aug 12, 2025 Risk: high
  Bicara Therapeutics Inc. reported a net loss of $27.388 million for the three months ended June 30, 2025, an increase from $17.049 million in the same period of
• Bicara Therapeutics Files Q1 2025 10-Q — May 13, 2025 Risk: medium
  Bicara Therapeutics Inc. filed its 10-Q for the period ending March 31, 2025. The company, located at 245 Main Street, Cambridge, MA, reported financial informa
• Bicara Therapeutics Files Q3 2024 10-Q — Nov 12, 2024 Risk: medium
  Bicara Therapeutics Inc. filed its 10-Q for the period ending September 30, 2024. The company, located at 245 Main Street, Cambridge, MA, is involved in pharmac

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX